Ramos José M, Romero David, Belinchón Isabel
Department of Internal Medicine, Hospital General Universitario de Alicante, Alicante, Spain.
Department of Medicine, Miguel Hernández University of Elche, Alicante, Spain.
PLoS Negl Trop Dis. 2016 Mar 3;10(3):e0004321. doi: 10.1371/journal.pntd.0004321. eCollection 2016 Mar.
Although incidence of leprosy in Spain has declined steadily over the years, the fivefold increase in immigration since the turn of the century--much of it from countries where leprosy is still prevalent--has been linked to an uptick in registered cases.
To describe the epidemiologic trends of incident leprosy cases detected in Spain among Spanish- and foreign-born population groups.
Observational, retrospective study of suspected leprosy cases in Spain, as reported through the System of Compulsory Notification of Diseases from 2003 to 2013, with results disaggregated by country of birth. We collected statistical data on leprosy burden for other countries from WHO to estimate the expected number of imported cases.
Of the 168 leprosy cases registered during the study period, 40 (24.6%) were in Spanish patients, while 128 (76.2%) were detected in legally resident immigrants. We identified a significantly higher number of imported leprosy cases during the 2008-2010 and 2011-2013 trienniums compared to the reference biennium 2003-2004 (OR 5.38, 95% CI 1.83-14.88 and OR 4.80, 95% CI 1.41-16.33, respectively). Most imported cases were diagnosed in Latin American immigrants (71.9%), especially Brazilians, but also Paraguayans, Bolivians and other nationalities from South and Central America. However, registered incidence was lower than expected for each year. For example, in 2003, the expected new cases in immigrants was 47.12, compared to only four cases that were actually detected (a 91% difference). Likewise, we expected to find 49.6 incident cases among immigrants in 2009, but only 15 new cases were reported (60% fewer than expected).
Imported cases of leprosy are responsible for most leprosy incidence in Spain, and we cannot rule out some under-diagnosis. Clinicians should be made more aware of the potential for leprosy incidence among patients from countries where the disease is endemic.
尽管多年来西班牙麻风病的发病率一直在稳步下降,但自世纪之交以来移民增加了五倍——其中大部分来自麻风病仍然流行的国家——这与登记病例的增加有关。
描述在西班牙检测到的麻风病新发病例在西班牙出生和外国出生人群中的流行病学趋势。
对2003年至2013年通过法定疾病报告系统报告的西班牙疑似麻风病病例进行观察性回顾研究,结果按出生国家分类。我们从世界卫生组织收集了其他国家麻风病负担的统计数据,以估计输入性病例的预期数量。
在研究期间登记的168例麻风病病例中,40例(24.6%)为西班牙患者,而128例(76.2%)在合法居住的移民中被检测到。与参考两年期2003 - 2004年相比,我们发现在2008 - 2010年和2011 - 2013年这两个三年期内输入性麻风病病例数量显著增加(分别为OR 5.38,95% CI 1.83 - 14.88和OR 4.80,95% CI 1.41 - 16.33)。大多数输入性病例在拉丁美洲移民中被诊断出来(71.9%),尤其是巴西人,但也有巴拉圭人、玻利维亚人和来自南美洲和中美洲的其他国籍人群。然而,每年登记的发病率低于预期。例如,2003年,移民中的预期新病例数为47.12例,而实际仅检测到4例(相差91%)。同样,我们预计2009年移民中会发现49.6例新发病例,但仅报告了15例新病例(比预期少60%)。
输入性麻风病病例是西班牙大多数麻风病发病的原因,我们不能排除一些漏诊情况。临床医生应更加意识到来自麻风病流行国家的患者中发生麻风病的可能性。